Prosight Management, LP
- SEC CIK
- 0001617201
- Latest filing
- Aug 14, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 15, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 38
- +3 vs. Q4 2024
- Portfolio value
- $304.3M
- −$52.6M (−14.7%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LKFTLakefront Biotherapeutics NV | SPON ADR | 1,314,898 | $33.0M | 10.9% | +289,898+28.3% | Added | History |
| MGTXMeiraGTx Holdings plc | COM | 3,691,546 | $25.0M | 8.2% | −699,291−15.9% | Reduced | History |
| BBIOBridgeBio Pharma, Inc. | COM | 610,000 | $21.1M | 6.9% | −385,000−38.7% | Reduced | History |
| JANXJanux Therapeutics, Inc. | COM | 689,901 | $18.6M | 6.1% | +360,133+109.2% | Added | History |
| ROIVRoivant Sciences Ltd. | SHS | 1,826,163 | $18.4M | 6.1% | +326,163+21.7% | Added | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 343,326 | $15.5M | 5.1% | −107,801−23.9% | Reduced | History |
| KURAKura Oncology, Inc. | COM | 2,078,315 | $13.7M | 4.5% | +753,315+56.9% | Added | History |
| ADCTADC Therapeutics SA | SHS | 9,543,004 | $13.5M | 4.4% | +28,004+0.3% | Added | History |
| ZYMEZymeworks Inc. | COM | 957,229 | $11.4M | 3.7% | +137,229+16.7% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 1,379,383 | $11.3M | 3.7% | +459,383+49.9% | Added | History |
| ICLRIcon PLC | COM | 60,099 | $10.5M | 3.5% | −24,901−29.3% | Reduced | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,480,000 | $9.87M | 3.2% | +391,294+35.9% | Added | History |
| ACHCAcadia Healthcare Company, Inc. | COM | 290,000 | $8.79M | 2.9% | −402,000−58.1% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 13,700 | $8.11M | 2.7% | +13,700 | New | History |
| SDGRSchrodinger, Inc. | COM | 385,000 | $7.60M | 2.5% | −335,500−46.6% | Reduced | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 609,252 | $7.48M | 2.5% | −10,748−1.7% | Reduced | History |
| TECXTectonic Therapeutic, Inc. | COM | 398,885 | $7.06M | 2.3% | +398,885 | New | History |
| ISRGIntuitive Surgical Inc | COM NEW | 14,000 | $6.93M | 2.3% | +14,000 | New | History |
| STTKShattuck Labs, Inc. | COM | 6,638,935 | $6.31M | 2.1% | 00.0% | Unchanged | History |
| ABCLAbCellera Biologics Inc. | COM | 2,815,652 | $6.28M | 2.1% | −4,534,348−61.7% | Reduced | History |
| IMVTImmunovant, Inc. | COM | 360,000 | $6.15M | 2.0% | +54,477+17.8% | Added | History |
| PRTAProthena Corp Public Ltd Co | SHS | 408,122 | $5.05M | 1.7% | −10,000−2.4% | Reduced | History |
| LIVNLivaNova PLC | SHS | 127,300 | $5.00M | 1.6% | +57,300+81.9% | Added | History |
| HAEHaemonetics Corp | COM | 65,400 | $4.16M | 1.4% | +18,700+40.0% | Added | History |
| BPMCBlueprint Medicines Corp | COM | 36,512 | $3.23M | 1.1% | −30,488−45.5% | Reduced | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 575,136 | $3.05M | 1.0% | +305,136+113.0% | Added | History |
| CTMXCytomX Therapeutics, Inc. | COM | 3,930,008 | $2.50M | 0.8% | +25,008+0.6% | Added | History |
| CDNACareDx, Inc. | COM | 136,593 | $2.42M | 0.8% | +56,593+70.7% | Added | History |
| BHVNBiohaven Ltd. | COM | 100,000 | $2.40M | 0.8% | +100,000 | New | History |
| ADUSAddus HomeCare Corp | COM | 24,045 | $2.38M | 0.8% | +24,045 | New | History |
| SGHTSight Sciences, Inc. | COM | 969,287 | $2.33M | 0.8% | +60,440+6.7% | Added | History |
| ERASErasca, Inc. | COM | 947,110 | $1.30M | 0.4% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 74,921 | $1.21M | 0.4% | −5,079−6.3% | Reduced | History |
| OKUROnKure Therapeutics, Inc. | COM CL A | 186,570 | $802.3K | 0.3% | +122,816+192.6% | Added | History |
| RNTXRein Therapeutics, Inc. | COM NEW | 430,000 | $761.1K | 0.3% | +25,021+6.2% | Added | History |
| MURAMural Oncology plc | ORD SHS | 422,743 | $532.7K | 0.2% | −44,079−9.4% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 334,263 | $451.3K | 0.1% | +334,263 | New | History |
| IMNMImmunome Inc. | COM | 23,618 | $158.9K | 0.1% | −30,724−56.5% | Reduced | History |
Sold out since Q4 2024 (3)
Positions held at the end of Q4 2024 that are gone from this filing.